Strata Skin Sciences, Inc. (NASDAQ:SSKN) is reporting third quarter financial results on Tuesday 10th November 2020, before market open.
According to analysts surveyed by Thomson Reuters, SSKN is expected to report 3Q20 loss of $ 0.04 per share from revenue of $ 4.90 million.
For the full year, analysts anticipate top line of $ 23.32 million, while looking forward to loss of $ 0.13 per share bottom line.
Previous Quarter Performance
Strata Skin Sciences, Inc. announced loss for the second quarter of $ 0.05 per share, from the revenue of $ 4.03 million. Wall street analysts are predicting, SSKN to report 2Q20 loss of $ 0.03 per share from revenue of $ 5.13 million. The bottom line results missed street analysts by $ 0.02 or 66.67 percent, at the same time, top line results fell short of analysts by $ 1.1 million or 21.44 percent.
Stock Performance
Shares of Strata Skin Sciences, Inc. traded low $ -0.02 or -1.56 percent on Monday, reaching $ 1.26 with volume of 42.10 thousand shares. Strata Skin Sciences, Inc. has traded high as $ 1.36 and has cracked $ 1.20 on the downward trend
According to the previous trading day, closing price of $ 1.26, representing a 70.67 % increase from the 52 week low of $ 0.75 and a 53.11 % decrease over the 52 week high of $ 2.73.
The company has a market capital of $ 42.53 million and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
Strata Skin Sciences, Inc. will be hosting a conference call at 8:30 AM eastern time on 10th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.strataskinsciences.com
STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions.
